A coalition led by Alphabet life sciences arm Verily that includes Nashville, Tenn.-based Vanderbilt University Medical Center has secured a $9.2 million National Institutes of Health award extension to advance a biology data analysis tool.
The FAIRplex platform allows researchers to apply AI and machine learning to find, access and analyze data from the Accelerating Medicines Partnership, a public-private collaboration featuring NIH and the FDA, to more deeply understand the biological systems affecting health and disease. The platform comprises clinical, molecular, phenotypic, and patient-reported outcomes data.
The group is shifting its focus from “foundational development to operational readiness and deeper integration,” per a Dec. 18 news release.
Other coalition members include Cambridge, Mass.-based Broad Institute of MIT and Harvard, Chicago-based Northwestern University Feinberg School of Medicine, and technology companies DataTecnica, Sage Bionetworks and Technome.
The post Vanderbilt, Verily partner on NIH-backed healthcare data platform appeared first on Becker’s Hospital Review | Healthcare News & Analysis.
Health IT
